Factor 8 and Factor 9 Deficient Plasmas
Factor-8 and Factor-9 Deficient Plasmas
Helena’s high-quality factor deficient plasmas are trusted worldwide by pharmaceutical and government customers, offering a reliable method for the quality control of haemophilia treatment products.
- Provides more accurate factor deficiency clotting time
- Residual factor activity of less than 1%
- Available guaranteed HiV and Hepatitis-negative
- Long-term shelf life and stability
Factor VIII and Factor IX Deficient Plasmas are widely used for the quality control of Haemophilia A and Haemophilia B treatment products.
Helena Biosciences offer a full range of Factor Deficient Plasmas in immunodepleted format, and our plasmas are available as guaranteed HIV and Hepatitis-negative.
Technical details
The intrinsic factor deficient plasmas are intended for the quantitative determination of specific factor activity in citrated human plasma. This one-stage method requires an appropriate APTT reagent and any instrument capable of performing APTT-based factor assay testing.
Kit contents
Factor 8 Deficient Plasmas:
|
Component |
REF |
Volume |
|---|---|---|
|
Factor VIII Deficient Plasma (Immunodepleted) |
5793 |
10 × 1 mL |
Factor 9 Deficient Plasmas:
|
Component |
REF |
Volume |
|---|---|---|
|
Factor IX Deficient Plasma (Immunodepleted) |
5794 |
10 × 1 mL |
Key: Liquid Lyophilised
Haemostasis assays 
Instruments 
